Market Tracker

05/25 8:15am ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

113.38
Delayed Data
As of May 24
 -0.44 / -0.39%
Today’s Change
87.50
Today|||52-Week Range
139.79
+11.58%
Year-to-Date
No recent news for Ligand Pharmaceuticals Inc.

Today’s Trading

Previous close113.82
Today’s open113.83
Day’s range113.30 - 114.86
Volume172,616
Average volume (3 months)253,436
Market cap$2.4B
Dividend yield--
Data as of 05/24/2017

Growth & Valuation

Earnings growth (last year)-101.05%
Earnings growth (this year)+25.40%
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)+51.53%
P/E ratioNM
Price/Sales19.42
Price/Book6.95

Competitors

 Today’s
change
Today’s
% change
HCMHutchison China Medi...+0.23+1.12%
AXONAxovant Sciences Ltd-0.24-1.05%
CLVSClovis Oncology Inc+0.50+0.91%
RAREUltragenyx Pharmaceu...+2.46+4.27%
Data as of 05/24/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)$0.42
Annual revenue (last year)$109.0M
Annual profit (last year)-$2.4M
Net profit margin-2.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
San Diego, California

Forecasts